ohm: My post was exactly what I represented it to

ohm: My post was exactly what I represented it to be: an effort to plausibly consider why CYDY was hiring a new CFO given a timing perspective that would likely have diverted attention from the buzz it had created by headlining Dr Jay's upcoming travel to ESMO in Munich. In other words, I was posing the possibility that these 2 seemingly disparate events may actually be somewhat related and, if so, why.

Aware that my hypothesis on the above topic was at the high end of the speculative ladder (note my shout out to MGK), I did try to subtly infuse it in a light hearted writing style that would befit such obvious guesswork on my part. But the only subtle satire I meant to convey (as an attempt at humor) were the 2 references to yesterday's board debate over who to blame for the Alzheimer’s study start up delay ( a debate that you and misui continued this morning).

As to your sage comment regarding the impossibility of the sale of the non oncology portion of the LL pipeline, you (and cardimine) are obviously correct that such a sale would require a SEC filing within a set number of days after its consummation. And no such filing has occurred. But although transactional closings and government filing tradecraft were never my thing, I strongly suspect that if CYDY and a buyer had wished to delay, for PR reasons, the effective date of the purchase agreement by adding a simple to meet contingency, the boys and girls at Sidley Austin would have been up to the task.

So, at the risk of repeating myself. -- my prior life demonstrated to me that deals don't always get successfully negotiated, even when the opportunity for mutual benefits dictates that they should. A successful outcome usually depends on how rationally each side assesses the dispersion of leverage between the parties. Headlining Dr Jay traveling to Munich gave me a sense of confidence that the much anticipated partnership agreement was at hand. However, inserting the new CFO into the news mix at this particular time suggested to me that his appointment might be connected to Munich in some way. If so, one possible explanation would be that the partnership negotiations had, unfortunately, failed, probably because the BP putative partners had overplayed their hand (leverage), thus making it advisable for Jay to announce the appointment of a permanent and highly qualified CFO who could help CYDY chart its own path over the next couple years with the help of vitally necessary cash from EMA granted Conditional Marketing Authorization revenues and the sale of the LL non oncology pipeline. As I thought I made quite clear, this is simply a hypothesis, premised entirely on how CYDY might respond if partnership negotiations had failed.

Now, you may find the above incredulous or even laughable, but it wasn't intended as satire, subtle or otherwise. All of it rests, not only on unverifiable speculation, but on the premise that notwithstanding the headlining of Munich by CYDY, it's possible that a successful partnership negotiation has not transpired over the last several months because reasonable terms were never offered. That premise is hopefully and likely invalid because any BP should realize by now the potential value of LL, and, accordingly, have offered reasonable and fair partnership terms to CYDY. In that case, Jay will be making a partnership announcement in Munich, and we can all assume that CYDY felt that Mr Hoffman will be just as valuable in a partnership setting as in a stand alone CYDY world.

As always, all he best.